Precigen to announce full year 2024 financial results and provide business updates on march 19th

Germantown, md. , march 13, 2025 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced the company will release full year 2024 financial results and provide business updates on wednesday, march 19, 2025.
PGEN Ratings Summary
PGEN Quant Ranking